TP53 and small cell lung carcinoma: We hypothesize that dysfunctional ferritin may act as a primary driver of ferroptosis susceptibility in SCLC, a process likely regulated synergistically by the characteristic loss of TP53/RB1 and MYC amplification in this malignancy.